pharma operations – Page 65

CSV not aligned to actual use during system upgrades – documentation pitfalls that trigger 483 observations

When CSV Fails to Align with Actual Use During System Upgrades: An Investigative Approach In the dynamic world of pharmaceutical manufacturing, the alignment of Computer System Validation (CSV) to actual…

Incomplete impact assessment during validation lifecycle – how to rebuild the evidence package for inspectors

Addressing Incomplete Impact Assessments in the Validation Lifecycle: Rebuilding Evidence for Inspections Incomplete impact assessments during the validation lifecycle can lead to significant regulatory scrutiny and potentially affect product quality.…

CSV not aligned to actual use during validation lifecycle – risk-based validation strategy aligned to FDA/EMA

Aligning CSV to Actual Use in the Validation Lifecycle: An Investigation Guide In the complex arena of pharmaceutical operations, the alignment of Computerized System Validation (CSV) with actual use during…

Incomplete impact assessment during inspection readiness – documentation pitfalls that trigger 483 observations

Assessing Documentation Pitfalls that Lead to Observations During Inspection Readiness In the complex world of pharmaceutical manufacturing, one common issue that can lead to FDA 483 observations is an incomplete…

PPQ acceptance criteria not met during inspection readiness – how to prevent repeat validation failures

How to Address PPQ Acceptance Criteria Failures During Inspection Readiness In the pharmaceutical manufacturing environment, meeting Process Performance Qualification (PPQ) acceptance criteria is fundamental to both compliance and operational success.…

Incomplete impact assessment during requalification planning – regulatory deficiency analysis and remediation roadmap

Analysis and Remediation Roadmap for Incomplete Impact Assessment in Requalification Planning In the pharmaceutical manufacturing sector, incomplete impact assessments during requalification can lead to significant regulatory deficiencies. These lapses are…

Periodic review overdue during validation lifecycle – risk-based validation strategy aligned to FDA/EMA

Investigating Periodic Review Overdue During the Validation Lifecycle In the realm of pharmaceutical manufacturing and quality assurance, having an overdue periodic review during the validation lifecycle can raise significant concerns…

Revalidation not triggered after change during tech transfer validation – risk-based validation strategy aligned to FDA/EMA

Addressing Revalidation Gaps Following Changes in Tech Transfer Validation In the dynamic environment of pharmaceutical manufacturing, ensuring compliance with validation protocols is crucial, particularly during tech transfers. A common observation…

Incomplete impact assessment during tech transfer validation – how to prevent repeat validation failures

Addressing Incomplete Impact Assessments in Tech Transfer Validation to Prevent Future Failures The pharmaceutical industry faces numerous challenges during the technology transfer of manufacturing processes and product formulations. One significant…

Periodic review overdue during validation lifecycle – documentation pitfalls that trigger 483 observations

Identifying the Risks of Overdue Periodic Reviews in the Validation Lifecycle In regulated pharmaceutical environments, maintaining compliance with Good Manufacturing Practices (GMP) is paramount. One common issue that can arise…

Inadequate worst-case justification during change control review – documentation pitfalls that trigger 483 observations

Understanding Inadequate Worst-Case Justification During Change Control Review to Avoid 483 Observations In the context of pharmaceutical manufacturing, an inadequate worst-case justification during change control reviews can lead to significant…

CSV not aligned to actual use during continued process verification – documentation pitfalls that trigger 483 observations

Contextualizing CSV Misalignments During Continued Process Verification to Prevent 483 Observations In the high-stakes world of pharmaceutical manufacturing, the alignment of computer system validation (CSV) to actual use is critical…